Meta-analysesA systematic review and meta-analysis of the prebiotics and synbiotics effects on glycaemia, insulin concentrations and lipid parameters in adult patients with overweight or obesity
Introduction
Overweight and obesity have been a global epidemic for several years, prevalent among children and adults, decreasing quality and expectancy of life [1], [2]. The excessive fat accumulation results in an alteration of carbohydrate [3] and lipid metabolism [4], a condition that can lead to the development of non-communicable diseases such as type 2 diabetes, dyslipidemia and cardiovascular diseases [5], [6]. Concerning the traditional treatments of obesity, which include diet, physical activity, as well as pharmacological and surgical treatment, the intestinal microbiota modulation has been a new therapeutic target in clinical trials to reduce the risks related to obesity [7].
It is firmly established that the gut microbiota differs between obese and lean individuals, both in composition and function, a difference that has also been found between diabetics and non-diabetics [8], [9]. Prebiotics and synbiotics may stimulate the growth and activity of beneficial bacteria like Lactobacillus and Bifidobacterium [10]. A dietary prebiotic is a selectively fermented ingredient that results in specific changes in the composition and/or activity of the gastrointestinal microbiota, thus conferring benefit(s) upon host health [10]. A dietary synbiotic is a product that contains both probiotics, which are live microorganisms that confer a health benefit on the host when administered in adequate amounts, and prebiotics [11]. Hence, they are being used to modulate gut microbiota with potential benefits for glucose homeostasis and lipid profile through mechanisms such as energy harvest, storage and expenditure from diet, satiety hormone balance, regulation of lipid synthesis and improvement in insulin resistance and the immune function [10].
Many studies have reported the effects of prebiotics, probiotics and synbiotics on metabolic outcomes, particularly the lipid profile and glucose homeostasis. Nevertheless, according to our search in databases, no systematic review or meta-analysis has evaluated the effect of prebiotics and synbiotics on these outcomes in overweight or obese individuals only. Therefore, we conducted a meta-analysis of randomized controlled trials in adults with overweight or obesity to provide a comprehensive summary of the literature concerning the effect of prebiotics and synbiotics on metabolic outcomes (total cholesterol, low density lipoprotein cholesterol – LDL-c, high density lipoprotein cholesterol – HDL-c, triglycerides, fasting glucose and fasting insulin).
Section snippets
Methods
The methods were consistent with the PRISMA (Preferred Reporting Items for Systematic Reviews and Meta-Analysis) statement [12].
Search results
A total of 1128 studies were identified through the database search. Of these, 463 duplicate articles and 37 articles published in languages other than English or Spanish were excluded. After reading titles and abstracts, 605 articles were excluded and 23 full-text articles were assessed for eligibility. Checking references resulted in two more papers. Finally, 14 articles (ten prebiotic and four synbiotic articles) were included. Among the fourteen selected articles, two were different
Discussion
To our knowledge, the present meta-analysis is the first that included trials performed only with overweight or obese individuals. Regarding prebiotics, a meta-analysis [32] suggested that the inulin had a lowering effect on total cholesterol, LDL-c and triglycerides concentrations in hyperlipidemic individuals. The characteristics of the meta-analysis were similar to ours in dose, treatment duration, sample size and mean age. When stratified for hyperlipidemia, these findings correspond with
Conclusion
The meta-analysis shows that, in general, prebiotics reduced plasma total cholesterol and LDL-c concentrations in adult subjects with overweight or obesity, and they also decreased plasma triglycerides and increase HDL-c concentrations in adult diabetic subjects with overweight or obesity, while synbiotics decreased plasma fasting insulin and triglycerides concentrations. Thus, the supplementation of prebiotics or synbiotics could take part in the management of obesity-related comorbidities,
Statement of authorship
Bruna Teles Soares Beserra, Ricardo Fernandes, Vinicius André do Rosario, Michel Carlos Mocellin, Marilyn Gonçalves Ferreira Kuntz and Erasmo Benicio Santos de Moraes Trindade contributed to conception and design of the study; Bruna Teles Soares Beserra, Ricardo Fernandes, Vinicius André do Rosario, Michel Carlos Mocellin and Marilyn Gonçalves Ferreira Kuntz contributed to drafting the manuscript; Michel Carlos Mocellin contributed to statistical analysis; Bruna Teles Soares Beserra, Ricardo
Conflicts of interest
No conflict of interests needs to be reported.
Acknowledgments
The authors are grateful to the Post-Graduate Program in Nutrition – Federal University of Santa Catarina, Brazil and Coordination of Improvement of Higher Education Personnel (CAPES)/Fellowship Program Social Demand for scholarship grant to the first five authors (BTSB, RF, VAR, MCM, MGFK).
References (40)
- et al.
The autocrine and paracrine roles of adipokines
Mol Cell Endocrinol
(2010) - et al.
Effects of synbiotic food consumption on metabolic status of diabetic patients: a double-blind randomized cross-over controlled clinical trial
Clin Nutr
(2014) - et al.
Synbiotic supplementation in nonalcoholic fatty liver disease: a randomized, double-blind, placebo-controlled pilot study
Am J Clin Nutr
(2014) - et al.
Yacon syrup: beneficial effects on obesity and insulin resistance in humans
Clin Nutr
(2009) - et al.
Chronic consumption of short-chain fructooligosaccharides does not affect basal hepatic glucose production or insulin resistance in type 2 diabetics
J Nutr
(2000) - et al.
Weight loss during oligofructose supplementation is associated with decreased ghrelin and increased peptide YY in overweight and obese adults
Am J Clin Nutr
(2009) - et al.
A mixture of trans-galactooligosaccharides reduces markers of metabolic syndrome and modulates the fecal microbiota and immune function of overweight adults
J Nutr
(2013) Dietary fructans and serum triacylglycerols: a meta-analysis of randomized controlled trials
J Nutr
(2007)Diabetic dyslipidemia: from evolving pathophysiological insight to emerging therapeutic targets
Can J Diabetes
(2013)- et al.
A potential decline in life expectancy in the United States in the 21st century
N Engl J Med
(2005)
Obesity: preventing and managing the global epidemic
Relationship between acute phase proteins and serum fatty acid composition in morbidly obese patients
Dis Markers
Standards of medical care in diabetes—2013
Diabetes Care
2013 AHA/ACC/TOS guideline for the management of overweight and obesity in adults: a report of the American College of Cardiology/American Heart Association Task force on practice guidelines and the obesity society
Circulation
Targeting gut microbiota in obesity: effects of prebiotics and probiotics
Nat Rev Endocrinol
Gut microbiota in human adults with type 2 diabetes differs from non-diabetic adults
PLoS One
A core gut microbiome in obese and lean twins
Nature
Prebiotic effects: metabolic and health benefits
Br J Nutr
World Gastroenterology Organisation global guidelines: probiotics and prebiotics October 2011
J Clin Gastroenterol
The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration
Ann Intern Med
Cited by (128)
The effects of inulin-type fructans on cardiovascular disease risk factors: systematic review and meta-analysis of randomized controlled trials
2024, American Journal of Clinical NutritionGalactomannans are the most effective soluble dietary fibers in type 2 diabetes: a systematic review and network meta-analysis
2023, American Journal of Clinical Nutrition